We are live on ! Find out more
SEC

Seven Eight Capital Portfolio holdings

AUM $1.11B
1-Year Est. Return 29.48%
This Fund
S&P 500
This Quarter Est. Return
+6.96%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$342M
AUM Growth
+$51.1M
Cap. Flow
+$47.6M
Cap. Flow %
13.91%
Top 10 Hldgs %
10.44%
Holding
675
New
141
Increased
130
Reduced
57
Closed
344

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$4.02M
2
NKE icon
Nike
NKE
+$3.8M
3
BMY icon
Bristol-Myers Squibb
BMY
+$3.69M
4
BNY
Bank of New York Mellon
BNY
+$3.63M
5
COST icon
Costco
COST
+$3.41M

Top Sells

Rank Stock Value
1
PNC icon
PNC Financial Services
PNC
+$3.04M
2
V icon
Visa
V
+$2.98M
3
PG icon
Procter & Gamble
PG
+$2.96M
4
PXD
Pioneer Natural Resource Co.
PXD
+$2.94M
5
CPGX
COLUMBIA PIPELINE GROUP IN COM STK (DE)
CPGX
+$2.82M

Sector Composition

Rank Sector Weight
1 Technology 15.97%
2 Industrials 12.49%
3 Consumer Discretionary 11.9%
4 Healthcare 11.63%
5 Consumer Staples 10.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XLNX
76
DELISTED
Xilinx Inc
XLNX
$1.43M 0.42%
26,232
+25,400
+3,053% +$1.31M
S
77
DELISTED
Sprint Corporation
S
$1.42M 0.41%
+214,000
New +$1.27M
AMCX icon
78
AMC Global Media
AMCX
$450M
$1.41M 0.41%
27,200
+24,000
+750% +$1.31M
AVGO icon
79
Broadcom
AVGO
$1.81T
$1.4M 0.41%
81,000
+65,000
+406% +$1.09M
GRA
80
DELISTED
W.R. Grace & Co.
GRA
$1.4M 0.41%
18,900
+7,500
+66% +$566K
MSCI icon
81
MSCI
MSCI
$42.2B
$1.38M 0.4%
16,399
-14,300
-47% -$1.22M
GWPH
82
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$1.37M 0.4%
+10,300
New +$984K
NVO
83
Novo Nordisk
NVO
$226B
$1.36M 0.4%
+65,360
New +$1.62M
KLAC icon
84
KLA
KLAC
$250B
$1.33M 0.39%
190,640
+40,640
+27% +$293K
ZAYO
85
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$1.32M 0.39%
44,400
+7,900
+22% +$229K
ITC
86
DELISTED
ITC HOLDINGS CORP
ITC
$1.32M 0.39%
28,364
+11,800
+71% +$546K
CBI
87
DELISTED
Chicago Bridge & Iron Nv
CBI
$1.31M 0.38%
46,747
+36,400
+352% +$1.18M
FDS icon
88
Factset
FDS
$10.1B
$1.3M 0.38%
+8,000
New +$1.38M
SNX icon
89
TD Synnex
SNX
$19.5B
$1.29M 0.38%
+22,600
New +$1.17M
CMI icon
90
Cummins
CMI
$88B
$1.28M 0.37%
+10,000
New +$1.21M
BERY
91
DELISTED
Berry Global Group, Inc.
BERY
$1.26M 0.37%
31,206
+21,780
+231% +$854K
ALB icon
92
Albemarle
ALB
$13.4B
$1.24M 0.36%
14,517
+4,200
+41% +$346K
AWK icon
93
American Water Works
AWK
$26.9B
$1.24M 0.36%
+16,496
New +$1.29M
ADSK icon
94
Autodesk
ADSK
$50.7B
$1.23M 0.36%
+17,031
New +$1.07M
YELP icon
95
Yelp
YELP
$1.5B
$1.23M 0.36%
29,531
+27,200
+1,167% +$953K
JPM icon
96
JPMorgan Chase
JPM
$947B
$1.22M 0.36%
18,300
+3,200
+21% +$209K
SE
97
DELISTED
Spectra Energy Corp Wi
SE
$1.2M 0.35%
+28,100
New +$1.07M
AGN
98
DELISTED
Allergan plc
AGN
$1.2M 0.35%
+5,200
New +$1.27M
STJ
99
DELISTED
St Jude Medical
STJ
$1.2M 0.35%
+15,016
New +$1.21M
HPE icon
100
Hewlett Packard
HPE
$58.8B
$1.19M 0.35%
90,157
-33,551
-27% -$414K
2 3
4
5 6

Similar funds

PP
Pegasus Partners Mequon, Wisconsin $1.07B AUM 32.32% 1-Year Est. Return
ECM
Ensemble Capital Management San Francisco, California $1.18B AUM 41.81% 1-Year Est. Return
GCAC
Guardian Capital Advisors (Canada) Toronto, Ontario, Canada $1.02B AUM 25.29% 1-Year Est. Return
CAM
ClariVest Asset Management San Diego, California $980M AUM 60.89% 1-Year Est. Return
D
Diversified Wilmington, Delaware $911M AUM 31% 1-Year Est. Return
GFS
GYL Financial Synergies West Hartford, Connecticut $1.33B AUM 34.46% 1-Year Est. Return
FTIS
First Trust Investment Solutions Naples, Florida $888M AUM 34.3% 1-Year Est. Return
AIA
Alera Investment Advisors Deerfield, Illinois $851M AUM 29.76% 1-Year Est. Return

Seven Eight Capital's Q3 2016 Portfolio in Review

As of Q3 2016, Seven Eight Capital held 675 positions worth $342M, up 18% from $291M the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Seven Eight Capital deployed $47.6M of net new capital in Q3 2016, opening 141 new positions and adding to 130 existing holdings. Its largest new stake was Teva Pharmaceuticals: 77,100 shares worth $3.55M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Mastercard, an estimated $2.55M trimmed.

  • Seven Eight Capital's largest Q3 2016 buy was Teva Pharmaceuticals: 77,100 shares worth $3.55M.
  • Seven Eight Capital added most to Bristol-Myers Squibb in Q3 2016, an estimated $3.69M increase.
  • Seven Eight Capital's biggest Q3 2016 reduction was Mastercard, cutting an estimated $2.55M.
  • Seven Eight Capital fully exited PNC Financial Services in Q3 2016, selling an estimated $3.04M.
  • Seven Eight Capital's ten largest holdings make up 10% of its $342M portfolio in Q3 2016.
  • Seven Eight Capital opened 141 new positions and closed 344 in Q3 2016.
  • Seven Eight Capital's portfolio value rose 18% quarter-over-quarter to $342M.

Based on Seven Eight Capital's 13F filing for Q3 2016, filed 14 Nov 2016.